The Loncar China BioPharma Index tracks the performance of a basket of companies that are leading China’s biotech revolution. With a focus on innovators, the index contains globally listed pharmaceutical companies, biotech companies, drug manufacturers, diagnostics companies, wholesalers, distributors and service providers that have a strategic role in growing China’s drug industry. It uses a modified equal-weighting methodology and contains both large pharmaceutical and growth-oriented biotechnology companies that are leading the region’s growth. The index will provide a metric to follow as this region plays an increasingly important role in the global biopharmaceuticals industry.
Click on a name to link to its website
Prices delayed up to 15 min
Loncar Investments, LLC : P.O Box 15072, Lenexa, KS 66285 : 913-871-5007 : Not investment advice or a solicitation to buy or sell securities